Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients

Conditions:   SLE;   Lupus Nephritis;   SGLT2 Inhibitors Interventions:   Drug: dapagliflozin;   Drug: placebo Sponsor:   Mansoura University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials